| Description |
1 online resource (x, 154 pages) : color illustrations |
| Series |
Perspectives on Sustainable Growth, 2199-8566 |
|
Perspectives on sustainable growth
|
| Contents |
About the Editor and Contributors; Chapter-1; Sustainable Development for the Health-Care Industry: Setting the Stage; Human Society Has Always Been Focused on Health; The Mission of the Health-Care Industry; The Life Cycle of Pharmaceutical Products; The Mega Trends Which Affect the Health-Care Industry; Societal Expectations for Personalized Medicine; The DNA of the Health-Care Industry: Evolving Management of Innovation; Sustainability and Pharmaceutical Products: Role in Human Health (Mistra Pharma 2009) |
|
Pharmaceutical Products and Contribution to Global Health: Global Health Requires More than Better DrugsSustainable Concerns All Along the Life Cycle of the Health-care Industry; R & D; Manufacturing and Supply Chain; Licensing and Market Access; Consumption of Health-Care Products: Use, Access, and Disease Management; Global Corporate Governance; Conclusion; References; Chapter-2; Can Innovation Still Be the Main Growth Driver of the Pharmaceutical Industry?; Innovation as a Driver of Growth for the Pharmaceutical Industry in the Past; The Pharmaceutical Industry Today |
|
The R & D Investments of Top Pharmaceutical CompaniesThe Output of Pharmaceutical R & D; The Pharmaceutical Innovation Process; The Success Rates of Pharmaceutical R & D; The Timelines of Pharmaceutical R & D; The Cost of Pharmaceutical R & D; A Steady-State R & D Model; The Reduced R & D Efficiency; Consequences of the Reduced R & D Efficiency; Increasing the Number of Projects in the R & D Pipeline; Reducing Costs of R & D; Measuring Performance and Managing the Project Portfolio Actively; Opening R & D Towards External Innovation; Sustainable Growth in Times of Reduced R & D Efficiency |
|
Increasing Pressure from Generic DrugsSustainability Must Come from R & D; References; The Importance of Understanding the 'Lived Experience' of Patients in Pharmaceutical Development Programmes; Chapter-3; Introduction; How Can We Make Sure We Look Beyond the Science and Capture the 'Human Being' in Our Data?; Is the Pharmaceutical Industry Brave Enough to Let Patients Contribute to Driving the Research Agenda?; So How Do We Facilitate This?; How Can We Benefit From This Sort of Research?; Building the Value Chain With Patients Playing a Key Role; So What Can We Do to Drive Change? |
|
Why Bother?Chapter-4; Listening to the Voice of the Patient to Facilitate Earlier Access to Promising Medicines: Interview with Sjaak Vink; Chapter-5; Drivers of the Real-World Data Revolution and the Transition to Adaptive Licensing: Interview with Dr. Richard Barker; CASMI (Center for the Advancement of Sustainable Medical Innovation); Chapter-6; Sustainable Development for the Healthcare Industry: Vantage Point from Emerging Economies; Introduction; Sustainable Commercialization; Roles Played by MNCs Versus Local Manufacturers in Emerging Economies; Vantage Point; Regulations |
| Summary |
This volume addresses the dynamics of sustainable development in the healthcare industry, covering all major aspects, including R & D, manufacturing, regulation, market access, commercialization, and general management.℗ Healthcare markets are evolving under demographic and economic pressures. In mature markets, patients navigate complex systems with limited control on healthcare quality and outcomes, while in developing markets, patients have limited awareness, access, and ability to pay for healthcare. The industry needs to identify which business targets are genuinely attractive for major or |
| Analysis |
ketenmanagement |
|
supply chain management |
|
logistiek |
|
logistics |
|
innovaties |
|
innovations |
|
economie |
|
economics |
|
bedrijfswetenschap |
|
management science |
|
duurzame ontwikkeling |
|
sustainable development |
|
gezondheidszorg |
|
health care |
|
Management studies, Business Administration, Organizational Science (General) |
|
Economics (General) |
|
Management, bedrijfskunde, organisatiekunde (algemeen) |
|
Economie (algemeen) |
| Notes |
Online resource; title from PDF title page (SpringerLink, viewed December 31, 2014) |
| Subject |
Medical economics.
|
|
Sustainable development.
|
|
Health Care Sector -- economics
|
|
Economics, Medical
|
|
sustainable development.
|
|
Management of specific areas.
|
|
Research & development management.
|
|
Sustainability.
|
|
Health economics.
|
|
BUSINESS & ECONOMICS -- Industries -- General.
|
|
Medical economics
|
|
Sustainable development
|
| Form |
Electronic book
|
| Author |
Morgon, Pierre A., editor
|
| ISBN |
9783319125268 |
|
3319125265 |
|
3319125257 |
|
9783319125251 |
|
